Search | Page 3 | Aplastic Anemia and MDS International Foundation

Search

Search results

  1. A call for action: Increasing enrollment of untreated patients with higher-risk myelodysplastic syndromes in first-line clinical trials.

    ... landscape of the management of patients with higher-risk myelodysplastic syndromes (HR-MDS). HMAs have improved hematopoiesis and quality of ...

    Research Article last updated 09/11/2017 - 9:04am.

  2. Progress in Myelodysplastic Syndromes: Clinicopathologic Correlations and Immune Checkpoints

    ... BACKGROUND: Myelodysplastic syndromes (MDS) are a group of clonal neoplasms characterized by ...

    Research Article last updated 09/11/2017 - 8:59am.

  3. Lenalidomide: Myelodysplastic syndromes with del(5q) and beyond

    ... Myelodysplastic syndrome (MDS) with deletion 5q (del(5q)) is a distinct ... Bone Marrow Diseases:  myelodysplastic syndromes (MDS) ...

    Research Article last updated 10/02/2017 - 9:54am.

  4. Differences in genomic patterns and clinical outcomes between African-American and White patients with myelodysplastic syndromes

    ... Bone Marrow Diseases:  myelodysplastic syndromes (MDS) ...

    Research Article last updated 09/18/2017 - 2:37pm.

  5. Defeating anaemia in myelodysplastic syndromes: another step forward

    ... Bone Marrow Diseases:  myelodysplastic syndromes (MDS) ...

    Research Article last updated 09/18/2017 - 2:23pm.

  6. Integrative Genomics Identifies the Molecular Basis of Resistance to Azacitidine Therapy in Myelodysplastic Syndromes

    ... Myelodysplastic syndromes and chronic myelomonocytic leukemia are blood disorders ...

    Research Article last updated 08/03/2017 - 9:16am.

  7. First-line Therapeutic Strategies for Myelodysplastic Syndromes.

    ... and subsequent prognostic stratification for patients with myelodysplastic syndrome (MDS) are often cumbersome, yet they are the basis of ... Bone Marrow Diseases:  myelodysplastic syndromes (MDS) ...

    Research Article last updated 09/11/2017 - 8:44am.

  8. Quality of life varies by diagnosis for MDS patients

    ... health-related quality of life (HRQOL) in patients with myelodysplastic syndromes (MDS) may differ based on disease risk at diagnosis, according to ...

    Article last updated 12/13/2017 - 12:25pm.

  9. Lenalidomide: Myelodysplastic syndromes with del(5q) and beyond

    ... Myelodysplastic syndrome (MDS) with deletion 5q (del(5q)) is a distinct ...

    Research Article last updated 10/23/2017 - 10:58am.

  10. HYPOMETHYLATING AGENTS (HMA) TREATMENT FOR MYELODYSPLASTIC SYNDROMES: ALTERNATIVES IN THE FRONTLINE AND RELAPSE SETTINGS

    ... agents (HMA) have played a pivotal role for treating myelodysplastic syndromes (MDS) over the past decade, inducing sustained hematological ...

    Research Article last updated 07/18/2017 - 1:15pm.